Skip Navigation


Radiation Protection Dosimetry Advance Access originally published online on July 12, 2007
Radiation Protection Dosimetry 2008 128(3):363-366; doi:10.1093/rpd/ncm366
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
128/3/363    most recent
ncm366v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bahreyni Toossi, M. T.
Right arrow Articles by Esmaili, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bahreyni Toossi, M. T.
Right arrow Articles by Esmaili, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Organ and effective doses of patients arising from coronary angiography and percutaneous transluminal coronary angioplasty at two hospitals in Mashhad-Iran

M. T. Bahreyni Toossi1,*, H. Zare1, S. Bayani1 and S. Esmaili2

1 Medical Physics Research Center, Bu Ali Research Institute, Mashad University of Medical Sciences, Mashad, Iran
2 Medical Physics Department, Faculty of Medicine, Mashad University of Medical Sciences, Mashad, Iran

* Corresponding author: bahreynimt{at}mums.ac.ir

Received December 26, 2006, amended May 28, 2007, accepted June 14, 2007

A detailed study of radiation doses received by 83 patients who underwent coronary angiography (CA) and 26 patients who underwent percutaneous transluminal coronary angioplasty (PTCA) by the femoral route in two hospitals in Mashhad-Iran is presented. All procedures were undertaken with Siemens angioscope X-ray equipment. Thermoluminescent dosimeters (TLD-100), suitably calibrated, were used to measure the dose received at five locations on the patient's skin (on the thyroid, gonads and lens of eyes). A dose area product (DAP) meter was also used. DAP values and fluoroscopy times were recorded for each patient. The mean values for DAP were 32.47 ± 4.03 and 44.49 ± 5.64 Gy cm2 for CA and PTCA, respectively. The patient dosimetry results revealed the thyroid receives the highest dose in CA and PTCA examinations. Also, in this study, DAP to effective dose conversion factors were estimated by means of a Rando phantom and the effective dose received by the patients was estimated for CA and PTCA examinations. The estimated mean values of effective dose were 6.75 ± 0.85 and 9.61 ± 1.24 mSv, respectively.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Radiat Prot DosimetryHome page
A. Mesbahi, N. Aslanabadi, and P. Mehnati
A STUDY ON THE IMPACT OF OPERATOR EXPERIENCE ON THE PATIENT RADIATION EXPOSURE IN CORONARY ANGIOGRAPHY EXAMINATIONS
Radiat Prot Dosimetry, December 16, 2008; (2008) ncn300v1.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.